These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33737716)

  • 1. Swiss-PO: a new tool to analyze the impact of mutations on protein three-dimensional structures for precision oncology.
    Krebs FS; Zoete V; Trottet M; Pouchon T; Bovigny C; Michielin O
    NPJ Precis Oncol; 2021 Mar; 5(1):19. PubMed ID: 33737716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing precision oncology in Latin America to improve patient outcomes: the status quo and a call to action for key stakeholders and decision-makers.
    de Castilla EMR; Mayrides M; González H; Vidangossy F; Corbeaux T; Ortiz N; Amaya C; Nuñez A; Jimbo DFJ; Ayensa A; Galindo M; Ruiz K; Pérez JM
    Ecancermedicalscience; 2024; 18():1653. PubMed ID: 38425763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus Statements on Precision Oncology in the China Greater Bay Area.
    Lam TC; Cho WC; Au JS; Ma ES; Lam ST; Loong HH; Wong JWH; Wong SNM; Lee VH; Leung RC; Lau JK; Kam MT; Mok FS; Lim FM; Nyaw JS; Tin WW; Cheung KM; Chan OS; Kwong PW; Cheung FY; Poon DMC; Chik JY; Lam MH; Chan LW; Wong SC; Cao YB; Hui CV; Chen JZ; Chang JH; Kong SF; El Helali A;
    JCO Precis Oncol; 2023 Jun; 7():e2200649. PubMed ID: 37315266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SWISS-MODEL Repository of annotated three-dimensional protein structure homology models.
    Kopp J; Schwede T
    Nucleic Acids Res; 2004 Jan; 32(Database issue):D230-4. PubMed ID: 14681401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Basic Documentation for Psycho-Oncology (PO-Bado): an innovative tool to combine screening for psychological distress and patient support at cancer diagnosis.
    Stadelmaier N; Duguey-Cachet O; Saada Y; Quintard B
    Psychooncology; 2014 Mar; 23(3):307-14. PubMed ID: 24123416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntheses, structures, and ion-exchange properties of the three-dimensional framework uranyl gallium phosphates, Cs4[(UO2)2(GaOH)2(PO4)4].H2O and Cs[UO2Ga(PO4)2].
    Shvareva TY; Sullens TA; Shehee TC; Albrecht-Schmitt TE
    Inorg Chem; 2005 Jan; 44(2):300-5. PubMed ID: 15651876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of Precision Oncology in the National Healthcare System: A Statement Proposal Endorsed by Italian Scientific Societies.
    Fasola G; Barducci MC; Tozzi VD; Cavanna L; Cinieri S; Perrone F; Pinto C; Russo A; Sapino A; Grossi F; Aprile G
    JCO Precis Oncol; 2023 Sep; 7():e2300166. PubMed ID: 37944071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision medicine in oncology: New practice models and roles for oncology pharmacists.
    Walko C; Kiel PJ; Kolesar J
    Am J Health Syst Pharm; 2016 Dec; 73(23):1935-1942. PubMed ID: 27864201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and psychometric evaluation of the Basic Documentation for Psycho-Oncology, a tool for standardized assessment of cancer patients.
    Knight L; Mussell M; Brandl T; Herschbach P; Marten-Mittag B; Treiber M; Keller M
    J Psychosom Res; 2008 Apr; 64(4):373-81. PubMed ID: 18374736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric Properties of the French Adaptation of the Basic Documentation for Psycho-Oncology (Po-Bado): A Distress Screening Tool.
    Stadelmaier N; Gana K; Saada Y; Duguey-Cachey O; Quintard B
    Behav Ther; 2017 Sep; 48(5):596-602. PubMed ID: 28711110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoting informed approaches in precision oncology and clinical trial participation for Black patients with cancer: Community-engaged development and pilot testing of a digital intervention.
    An J; Ferrante JM; Macenat M; Ganesan S; Hudson SV; Omene C; Garcia H; Kinney AY
    Cancer; 2024 Oct; 130 Suppl 20():3561-3577. PubMed ID: 37837177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational Study.
    Powell SF; Dib EG; Bleeker JS; Keppen MD; Mazurczak M; Hack KM; Gitau MM; Steen PD; Terstriep SA; Reynolds J; Landsverk ML; Chan CH; Nelson ME; Thompson PA; Ellison C; Black LJ; Ford JM; Chung JH; Anhorn R; Gaba AG
    JCO Precis Oncol; 2018 Nov; 2():1-12. PubMed ID: 35135120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a tool for palliative care needs assessment and intervention: mixed methods research at a Swiss tertiary oncology clinic.
    Domeisen Benedetti F; Fringer A; Attoun-Knobel S; Schmidt EB; Strasser F; Schlögl M; Blum D
    Ann Palliat Med; 2023 May; 12(3):496-506. PubMed ID: 37038058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Database of evidence for precision oncology portal.
    Sun SQ; Mashl RJ; Sengupta S; Scott AD; Wang W; Batra P; Wang LB; Wyczalkowski MA; Ding L
    Bioinformatics; 2018 Dec; 34(24):4315-4317. PubMed ID: 30535306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital process orientation from an operations management perspective: development of a measurement tool and practical testing in three ophthalmic practices.
    Gonçalves PD; Hagenbeek ML; Vissers JM
    BMC Health Serv Res; 2013 Nov; 13():475. PubMed ID: 24219362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision Medicine in Oncology Pharmacy Practice.
    Saadeh C; Bright D; Rustem D
    Acta Med Acad; 2019 Apr; 48(1):90-104. PubMed ID: 31264437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PredictONCO: a web tool supporting decision-making in precision oncology by extending the bioinformatics predictions with advanced computing and machine learning.
    Stourac J; Borko S; Khan RT; Pokorna P; Dobias A; Planas-Iglesias J; Mazurenko S; Pinto G; Szotkowska V; Sterba J; Slaby O; Damborsky J; Bednar D
    Brief Bioinform; 2023 Nov; 25(1):. PubMed ID: 38066711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision oncology: a clinical and patient perspective.
    Lassen UN; Makaroff LE; Stenzinger A; Italiano A; Vassal G; Garcia-Foncillas J; Avouac B
    Future Oncol; 2021 Oct; 17(30):3995-4009. PubMed ID: 34278817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional precision oncology: Testing tumors with drugs to identify vulnerabilities and novel combinations.
    Letai A; Bhola P; Welm AL
    Cancer Cell; 2022 Jan; 40(1):26-35. PubMed ID: 34951956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial Intelligence for Precision Oncology.
    Bhalla S; Laganà A
    Adv Exp Med Biol; 2022; 1361():249-268. PubMed ID: 35230693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.